The Frequency of Resistance to Synthetic Erythropoietin and Its Risk Factors among Chronic Hemodialysis Patients in Kerman

Publish Year: 1397
نوع سند: مقاله ژورنالی
زبان: English
View: 78

This Paper With 10 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_JKMU-25-1_007

تاریخ نمایه سازی: 19 دی 1401

Abstract:

Background: The aim of this study was to determine the frequency of resistance to synthetic erythropoietin and factors affecting it among chronic hemodialysis patients in Kerman/ Iran. Methods: This cross- sectional study was performed on chronic hemodialysis patients of three hemodialysis centers in Kerman, Iran during ۳ successive months in the summer of ۲۰۱۶. Women with hemoglobin less than ۱۱ and men with hemoglobin less than ۱۲ were included in the study and using medical records, their sex, age, hemoglobin level, the amount of administered erythropoietin, tests of ferritin profile, and CPR and PTH levels were extracted and entered in a questionnaire. Patients were divided into the two groups of resistant to medication (received ۳۰۰ units or more erythropoietin for each kilogram body weight in week for reaching the target hemoglobin) and the group who did not have resistance. Then, the two groups were compared in terms of mentioned factors. Results: The frequency of resistance to synthetic erythropoietin was generally ۳۳.۶۶% and it was ۳۲.۴%in females and ۶۷.۶% in males that shows no significant difference between the two sexes (p=۰.۰۷۹). Among the studied factors, low ferritin level (P=۰.۰۱۲) and CRP level (p= ۰.۰۰۱) showed significant relationship with resistance to erythropoietin. Conclusion: Since, iron- deficiency anemia presented with low ferritin level, and high CRP level which indicates infection and inflammation had the greatest relationship with resistance to synthetic erythropoietin, removing causes of infection and iron-deficiency anemia in hemodialysis patients in order to reduce the use of costly synthetic erythropoietin is recommended.

Keywords:

Anemia , Hemodialysis , Resistance to synthetic erythropoietin

Authors

Abbas Etminan

Nephrologist, Assistant Professor, Shafa Clinical Research Committee, Kerman University of Medical Sciences, Kerman, Iran

Seyed Mostafa Seyed Askari

Student Research Committee, Kerman University of Medical Sciences, Kerman, Iran

Farah Pouramiri

Internal Medicine, Afzalipour School of Medicine, Kerman University of Medical Sciences, Kerman, Iran

Mina Sharifinjad

Dialysis Center Nurse, Shafa Clinical Research Committee, Kerman University of Medical Sciences, Kerman, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Regidor DL, Kopple JD, Kovesdy CP, Kilpatrick RD, McAllister CJ, ...
  • Sarnak MJ, Tighiouart H, Manjunath G, MacLeod B, Griffith J, ...
  • Al-Ageel NA, Al-Aqeel SA, Abanmy NO, Alwakeel JS, Sabry A, ...
  • Kazmi WH, Kausz AT, Khan S, Abichandani R, Ruthazer R, ...
  • Lopez-Gomez JM, Portoles JM, Aljama P. Factors that condition the ...
  • Daugirdas JT, Blake PG, Ing TS. Handbook of Dialysis. ۴th ...
  • NKF-DOQI clinical practice guidelines for the treatment of anemia of ...
  • DeAngelo AJ, Bell DG, Quinn MW, Long DE, Ouellette DR. ...
  • Lundby C, Thomsen JJ, Boushel R, Koskolou M, Warberg J, ...
  • Revicki DA, Brown RE, Feeny DH, Henry D, Teehan BP, ...
  • Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Tonelli M, ...
  • Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW. ...
  • Astor BC, Coresh J, Heiss G, Pettitt D, Sarnak MJ. ...
  • Arcasoy MO. The non-haematopoietic biological effects of erythropoietin. Br J ...
  • Vaziri ND, Zhou XJ. Potential mechanisms of adverse outcomes in ...
  • Liu J, Guo H, Gilbertson D, Foley R, Collins A. ...
  • Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, ...
  • Locatelli F, Aljama P, Bárány P, Canaud B, Carrera F, ...
  • Ribeiro S, Costa E, Belo L, Santos-Silva A. rhEPO for ...
  • Daqing Hong. Erythropoietin hyporesponsiveness is more likely among female than ...
  • Bamgbola OF, Kaskel FJ, Coco M. Analyses of age, gender ...
  • Lea JP, Norris K, Agodoa L. The role of anemia ...
  • Kalantar-Zadeh K, Ikizler TA, Block G, Avram MM, Kopple JD. ...
  • Bamgbola O. Resistance to erythropoietin-stimulating agents: etiology, evaluation, and therapeutic ...
  • Li S, Foley RN, Collins AJ. Anemia, hospitalization, and mortality ...
  • Besarab A, Amin N, Ahsan M, Vogel SE, Zazuwa G, ...
  • Lin CL, Hung CC, Yang CT, Huang CC. Improved Anemia ...
  • Rao DS, Shih MS, Mohini R. Effect of serum parathyroid ...
  • Panichi V, Rosati A, Bigazzi R, Paoletti S, Mantuano E, ...
  • El-Khatib M, Duncan HJ, Kant KS. Role of C-reactive protein, ...
  • Nand N, Chugh M, Sharma M. Effect of erythropoietin on ...
  • Bárány P, Divino Filho JC, Bergström J.High C-reactive protein is ...
  • نمایش کامل مراجع